Single specialty healthcare centres are throwing up opportunities for emerging businesses and private equity investors, there are certain challenges that startups operating in the sector are facing
Read More
The Modi government is all set to delink the medical device industry from the pharmaceutical sector and will shortly notify a change in the current drug rules
Read More
Amgen expects to complete the transition in the majority of these emerging markets within a 12-month period. It expects the deal to add to its adjusted earnings beginning in 2017
Read More
India has a meagre 1,500 well equipped inspectors for more than 10,000 factories engaged in pharmaceutical products leading to country's products facing regulatory hurdles in the overseas markets like the US which follow stringent protocols for the manufacturing processes, a sectoral study done by Assocham and research firm RNCOS has pointed
Read More
Lack of enough protein in diet is a common worry among vegetarians. And if you’re one of them, you need to consider how to boost your protein intake
Read More
The dietary supplements market in India is estimated to be about $2 billion and is likely to double to $4 billion by 2020
Read More
In a tie-up with U.S. generic drugmaker Mylan NV, the Bengaluru-based biopharmaceutical firm has five biosimilar products - almost identical copies of original drugs - entering global regulatory approval stage which is expected to take about 18-20 months
Read More
Roche had agreed in 2013 to pay privately held partner Polyphor up to 500 million Swiss francs ($485.3 million) for rights to the product, marking a rare foray by a major pharmaceuticals company into the battle against superbug infections in hospitals
Read More
